Fuelled by a visionary leadership team and a diverse, high-caliber Board, PharmaNest is rapidly expanding its circle of passionate scientific and clinical advisors who are accelerating breakthroughs in fibrosis research.
Executive Team
Mathieu Petitjean, Ph.D.
CEO
Mathieu brings over 25 years of global leadership experience in healthcare imaging, diagnostics, and digital innovation, including senior roles at GE Healthcare. With over 50 publications, his work advances AI-driven fibrosis quantification and the standardization of quantitative histopathology.
Li Chen, Ph.D.
Principal Investigator
Li is an experienced pharmaceutical research scientist well-versed in both in-vitro and in-vivo workflows. She leads PharmaNest’s translational studies quantifying fibrosis phenotypes via single-fiber digital pathology and AI analytics
Philippe Nore, MBA
Chief Business Officer
Bringing over 25 years of global life-sciences commercialization and business development experience (including roles at major firms such as Roche and Adaptive Biotechnologies), Philippe leads PharmaNest’s strategic partnerships, growth initiatives and market-launch efforts for its digital pathology and fibrosis-biomarker platforms
MD, To be Announced - Q4 2025
CMO
Offices:
100 Overlook Center, FL2, Princeton, NJ 08540
FibroNest Operations:
We deliver FibroNest worldwide via the Cloud.